The program currently supports 1,100 children and works with diabetes centers in 18 countries to provide clinical care and diabetes education. It also aims to raise awareness of the plight of children with diabetes in these countries and encourages governments to establish appropriate care to safeguard the future of children with diabetes.
According to IDF, 70,000-75,000 children in low-income and lower-middle income countries are living with diabetes in desperate circumstances. These children need life-saving insulin to survive. Even more children are in need of the monitoring equipment, test strips and education required to manage their diabetes and avoid the life-threatening complications associated with the disease.
In many developing countries, particularly in sub-Saharan Africa and some parts of Asia, life-saving diabetes medication and monitoring equipment is often unavailable or unaffordable. As a result, many children with diabetes die soon after diagnosis, or have poor control and quality of life, and develop the devastating complications of the disease early.
Few governments in sub-Saharan Africa are able to provide free insulin to children, according to IDF. Families often must purchase the insulin at premium prices that may equal more than half the family income.
"For any child with diabetes, having access to insulin, a life-saving
and life-sustaining medication, should be a right not a privilege," said
Dr. Martin Silink, President of the International Diabetes Federation. "The
discovery of insulin 87 years ago was hailed as a miracle. Yet today many
children with diabetes in the developing world still face death because
they cannot access or afford this miracle drug. Solving the complex issues
needed for a sustainable supply chain of insulin and oth
|SOURCE Eli Lilly and Company|
Copyright©2008 PR Newswire.
All rights reserved